Posted by Michael Wonder on 27 Aug 2022
Novavax COVID-19 vaccine approved for 12 to 17s by MHRA
26 August 2022 - The Medicines and Healthcare products Regulatory Agency has concluded that Nuvaxovid is safe and effective in this age group.
The approval follows a review of the safety, quality and effectiveness of the vaccine in this age group, and expert advice from the government’s independent scientific advisory body, the Commission on Human Medicines.
